IBVIS - Trademark Details
Status: 681 - Publication/Issue Review Complete
Image for trademark with serial number 79296446
Serial Number
79296446
Word Mark
IBVIS
Status
681 - Publication/Issue Review Complete
Status Date
2022-02-08
Filing Date
2020-08-11
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2022-03-15
Law Office Assigned Location Code
N50
Employee Name
MAJCHER HARTNETT, MEGA
Statements
Goods and Services
Designing of machines, apparatus, instruments, machine parts, and systems composed of such machines, apparatus and instruments; pharmaceutical, medicine, chemical and engineering design services; computer software design, computer programming, and maintenance of computer software; designing, programming and maintenance of computer software having artificial intelligence functionality; computer software design, computer programming, and maintenance of computer software for use in scientific and technical analysis of data from artificial intelligence; computer software design, computer programming, and maintenance of computer software for use in analysis, testing, screening, designing, development or research on nucleic acids, pharmaceuticals or chemicals; computer software design, computer programming, and maintenance of computer software for use in drug discovery screening; computer software design, computer programming, and maintenance of computer software for analyzing and assaying messenger RNA (mRNA) substructures; computer program design, computer programming, and maintenance of computer program for databases; computer software design, computer programming, and maintenance of computer software for use in genome research or the development of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments or foodstuffs; information processing using computers, namely, providing online nondownloadable software for processing of data regarding RNA and RNA-compound interaction by computers for use in developing new drugs; technical advice relating to computers, computers for automobiles and other computers for industrial machines requiring highly specialized knowledge, skills and experiences for proper operation; scientific and technical research consultancy in the field of life information science, nucleic acids diagnosis and drug discovery, and research and development relating thereto; analysis and research in the field of life information science and technology, namely, analysis and research on target identification and validation, and prediction of structure and function of proteins and nucleic acids; laboratory research and development of new products for others in the field of life information science, nucleic acids diagnosis and drug discovery; scientific and technological services, namely, biochemical and biological testing, inspection of medical and chemical goods for quality control purposes, efficacy and quality analysis of medical and chemical products, medical and chemical product development and research; chemical analysis and screening on chemicals, namely, chemical product quality evaluation; screening on pharmaceuticals, namely, pharmaceutical product evaluation; scientific research, testing and analysis in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicines, chemicals and engineering; research services in the field of biological science, namely, isolation, purification, analysis, screening and research on DNA, RNA and other biological materials; quality assessment services, namely, quality control and evaluation for others; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; development and research on pharmaceuticals targeting messenger RNA (mRNA) substructures, and providing information and consultancy relating thereto; Scientific and technological services, namely, testing, inspection, analysis, surveying, development and research on small molecule compounds, antisense oligonucleotides and compounds, and providing information and consultancy relating thereto; analysis, surveying and development of pharmaceuticals, and providing information and consultancy relating thereto; testing, inspection and research for drug development and medical research purposes, and providing information and consultancy relating thereto; testing and research on biotechnology and providing information and consultancy relating thereto; medical and biological research in the nature of genomic experiments, analyses, research, assays, testing, inspection and detection of medical and biological products for efficacy and quality evaluation; consultancy, advice and providing information on medical and biological research in the nature of genomic experiments, analyses, research, assays, testing, inspection and detection of medical and biological products for efficacy and quality evaluation; testing, surveying, research and data analysis for research purposes in the field of biomedicine, genome biology, pharmacogenomics, diagnostics, clinical trials or bioengineering; testing, inspection and research of chemicals or reagents; research and development of vaccines and medicines; research and development of vaccines and medicines; consultancy and providing information on testing, inspection and research of pharmaceuticals, chemicals, reagents, cosmetics or foodstuffs; conducting clinical trials for others on pharmaceuticals; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock breeding or fisheries; testing the functionality of and research on machines, apparatus and instruments; rental of measuring apparatus; rental of computers; providing computer programs on data networks, namely, providing temporary use of non-downloadable computer software for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; cloud computing, namely, providing temporary use of on-line non-downloadable cloud computing software for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; software as a service (SaaS) services featuring software for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; electronic storage services for archiving electronic data; providing electronic data server storage services on the internet; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; providing temporary use of online non-downloadable computer software for analysis of science and technology data based on artificial intelligence (AI) technology; providing temporary use of online non-downloadable computer software for use in analysis, testing, screening, designing, development or research of nucleic acids, pharmaceuticals or chemicals; providing temporary use of online non-downloadable computer software for use in drug discovery screening; providing temporary use of online non-downloadable computer programs on data networks for analyzing and assaying messenger RNA, or mRNA, substructures; providing temporary use of online non-downloadable computer programs for creating, accessing, managing and searching databases; providing temporary use of online non-downloadable computer software for use in genome research and the development of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments or foodstuffs; rental of laboratory apparatus and instruments
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-10-26
Primary Code
042
Current Trademark Owners
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Theodore R. Remaklus
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1556621
International Registration Date
2020-08-11
International Publication Date
2020-10-22
International Renewal Date
2030-08-11
Auto Protection Date
2022-04-22
International Status
001 - Request for extension of protection established
International Status Date
2020-10-22
Priority Claimed In
True
Priority Claimed Date
2020-02-26
First Refusal In
True
Trademark Events
Event DateEvent Description
2020-10-22SN ASSIGNED FOR SECT 66A APPL FROM IB
2020-10-26NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-10-30APPLICATION FILING RECEIPT MAILED
2020-12-06ASSIGNED TO EXAMINER
2020-12-14NON-FINAL ACTION WRITTEN
2020-12-15NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2020-12-28REFUSAL PROCESSED BY MPU
2020-12-29NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2021-01-15REFUSAL PROCESSED BY IB
2021-06-23TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-06-23CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-06-23TEAS/EMAIL CORRESPONDENCE ENTERED
2021-07-27PRIORITY ACTION WRITTEN
2021-07-27PRIORITY ACTION E-MAILED
2021-07-27NOTIFICATION OF PRIORITY ACTION E-MAILED
2022-01-07TEAS RESPONSE TO OFFICE ACTION RECEIVED
2022-01-07CORRESPONDENCE RECEIVED IN LAW OFFICE
2022-01-07TEAS/EMAIL CORRESPONDENCE ENTERED
2022-02-04EXAMINERS AMENDMENT -WRITTEN
2022-02-04EXAMINERS AMENDMENT E-MAILED
2022-02-04NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2022-02-04EXAMINER'S AMENDMENT ENTERED
2022-02-04APPROVED FOR PUB - PRINCIPAL REGISTER
2022-02-06ASSIGNED TO LIE